SGK1 and diabetes mellitus: This is the first study to investigate the role of SGK (Serum- and Glucocorticoid-inducible Kinase 1) genetic variance in two independent prediabetic diabetes risk populations (TUEF and EUGENE2), including a confirmatory analysis in a third independent, older population that includes both diabetic and non-diabetic individuals (METSIM).